Neoadjuvant chemotherapy with angiogenesis inhibitor in early-stage breast cancer: a systematic review and meta-analysis - Poll - MDSpire

Neoadjuvant chemotherapy with angiogenesis inhibitor in early-stage breast cancer: a systematic review and meta-analysis

  • By

  • Jiangzhuo Wu

  • Hanbing Li

  • Ling Wei

  • Xiao Yan

  • Jiang Fang

  • Lin Peng

  • Xiaobo Zhao

  • July 15, 2026

Share

Original Source(s)

Neoadjuvant chemotherapy with angiogenesis inhibitor in early-stage breast cancer: a systematic review and meta-analysis

  • by Jiangzhuo Wu, Hanbing Li, Ling Wei, Xiao Yan, Jiang Fang, Lin Peng, Xiaobo Zhao

  • July 15, 2026

Related Content

Gastrointestinal toxicity associated with cyclin-dependent kinase 4/6 inhibitors in breast cancer patients: insights from a real-world pharmacovigilance analysis

Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis

Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report